Prevention of pulmonary complications by 6-methylprednisolone in major abdominal surgery

G C Zotti1, F Salzano de Luna, A Caiazza

  • 1Istituto di Chirurgia Generale I e Trapianti d'Organo II Facoltà di Medicina e Chirurgia, Università di Napoli.

The Italian Journal of Surgical Sciences
|January 1, 1988
PubMed

Insights

Methylprednisolone sodium succinate (MPSS) effectively prevented respiratory complications in major abdominal surgery patients. This steroid treatment significantly reduced pulmonary issues compared to placebo, improving patient outcomes.

Area of Science:

  • Anesthesiology
  • Surgical Critical Care
  • Pharmacology

Background:

  • Major abdominal surgeries pose a risk of postoperative respiratory complications.
  • Prophylactic interventions are crucial for mitigating these risks and improving patient recovery.

Purpose of the Study:

  • To evaluate the efficacy of methylprednisolone sodium succinate (MPSS) in preventing respiratory complications after major abdominal surgery.
  • To compare MPSS versus placebo in a randomized, double-blind study design.

Main Methods:

  • A randomized, double-blind, placebo-controlled study was conducted.
  • Patients undergoing abdominal vascular, pancreatic, or hepatic surgery were included.
  • Respiratory complications were monitored in both MPSS and placebo groups.

Main Results:

  • A significantly lower incidence of pulmonary complications was observed in the MPSS group (4.8%) compared to the placebo group (22.5%).
  • The difference in complication rates between the groups was statistically significant (p < 0.05).

Conclusions:

  • Methylprednisolone sodium succinate demonstrates significant potential in preventing respiratory complications following major abdominal surgery.
  • MPSS may be a valuable therapeutic option for reducing postoperative pulmonary morbidity in surgical patients.